Our Esteemed Speakers
We are honored to welcome a distinguished panel of speakers who are pioneers in the field of toxicologic pathology, oncology research, and pharmaceutical sciences. With decades of experience spanning academia, regulatory agencies, and leading pharmaceutical companies, these experts bring a wealth of knowledge that is both deep and rare. Each speaker has significantly contributed to the advancement of science through groundbreaking research, regulatory leadership, and global collaborations.
Their insights, drawn from real-world experience and cutting-edge innovation, promise to enrich our understanding of oncology and toxicology in ways few can. This is not just a lineup of professionals — it's a gathering of minds shaping the future of medicine.
Conference Speakers (Day 1 - Nov 7)
Dr. Gabriele
Pohlmeyer-Esch
DVM, Dipl. ECVP - Director of Pathology at Boehringer Ingelheim Pharma, Germany with 30+ years of experience in toxicologic pathology
Conference Topic
The Concept of Adversity in Anatomic Toxicologic Pathology
View More

Dr. Lindsay Tomlinson
DVM, DVSc – Senior veterinary pathologist with 23+ years in toxicologic pathology at Pfizer and Bristol-Myers Squibb.
Conference Topic
Biomarkers of Adversity
View More

Dr. Sibylle Groeters
Dipl. ECVP – Vice President and Senior Executive Expert in Toxicology at BASF SE, Germany, with 20+ years of experience in toxicologic pathology.
Conference Topic
Adversity Considerations in Relation to the Agrichemical Industry
View More

Dr. Renee Hukkanen
DVM, MS, Diplomate ACVP – Director of Pathology at Amgen, Inc. with experience in toxicologic pathology across pharma, chemical, and regulatory sectors.
Conference Topic
NOAEL and Adversity Assessment in Oncology Drug Development
View More

Dr. Sunish Mohanan
BVSc, MS, PhD, Diplomate ACVP – Senior Director of Research Pathobiology at Gilead Sciences with expertise in oncology, immunotoxicology, and drug safety.
Conference Topic
Immune System Adversity: Challenges and Insights in Toxicologic Pathology
View More

Dr. Brian W. Soper
PhD - Senior Scientific Engagement Manager, The Jackson Laboratory, USADr.; expert in humanized mouse platforms and immune modulation.
Conference Topic
Human HSC & PBMC Platforms for In Vivo Immune Modulatory Drug Discovery
View More

Dr. Klaus Weber
DVM, PhD, MSBiol, DJSTP –
Founder, AnaPath Services GmbH, Switzerland Expert in toxicologic and human pathology with 25+ years’ experience. Specializes in neuropathology, inhalation path-ology, and oncogenicity studies.
Conference Topic
Innovations and Challenges in Neuropathology for Nonclinical Toxicology Studies
View More

Conference Speakers (Day 2 - Nov 8)
Dr. Ken Frazier
DVM, PhD – Experimental nephrologist and retired toxicologic pathologist from GSK; expert in drug-induced kidney injury.
Conference Topic
Renal Toxicity Associated with Novel Therapeutics
View More

Dr. Shim-mo Hayashi
DVM, PhD – Fellow at Japan’s National Institute of Health Sciences and Visiting Professor at Tokyo University of Agriculture and Technology, expert in food safety and toxicologic pathology.
Conference Topic
Health Foods and Risk Assessment: Regulatory and Safety Aspects
View More

Dr. Deepa Rao
BVSc, MS, PhD, DABT, DACVP – Consulting veterinary pathologist at Greenfield Pathology Services with deep expertise in neurotoxicology and regulatory toxicologic pathology.
Conference Topic
Drug-Induced Sensory Neuropathy: Getting Aligned to Detect & Trans-late Neurotoxicity
View More

Dr. Padma Kumar
Narayanan
BVSc, MS, PhD – Vice President and Head of Preclinical & Clinical Development Sciences at Wave Life Sciences, specializing in RNA thera-peutics and immunotoxicology.
Conference Topic
Nonclinical Safety Assessment of Novel Oligonucleotide Therapies Intended for CNS Delivery
View More

(IATP Maronpot Guest Lecture)
Dr. Bhanu Pratap Singh
BVSc, MS, DACVP, DABT, FIATP
Senior Director, Nonclinical Safety and Pathobiology, Gilead Sciences Inc, USA
Conference Topic
Developing Long-Acting Injectable (LAIs): Non-Clinical Strategies and Considerations for Local Tolerability in Animal Models
View More

Dr. Alok Sharma
BVSc, MVSc, MS, PhD, DACVP, DABT Director, Global Anatomic Pathology at Labcorp, with specialization in nervous system toxicologic pathology and direct CNS delivery studies.
Conference Topic
Direct CNS Delivery of Non-traditional Modalities: Navigating Technical Aspects and Pathology
View More

Conference Speakers (Day 3 - Nov 9)
Dr. Kuldeep Singh
BVSc, MS, PhD, Diplomate ACVP -Head of Pathology at Wave Life Sciences, specializing in toxicologic and investigative pathology with extensive experience in oligo-nucleotide therapeutics.
Conference Topic
Preclinical Safety Findings Asso-ciated with Systemically Admi-nistered Oligonucleotides (ASOs and siRNAs) and Strategies to Adjudicate Them
View More

Dr. Dinesh Bangari
BVSc, MVSc, PhD – Senior Director, Global Pathology, Pfizer Inc., USA -Expert in discovery toxicology and advanced in-vitro systems with a focus on integrating AI/ML in pathology workflows.
Conference Topic
New Advanced Methodologies (Organoids, Organ-on-Chips, etc.) in Discovery Toxicology and AI/ML in Pathology
View More

Tijo Thomas
Head of Software Development at AIRA MATRIX, specializing in AI/ML-powered digital pathology and preclinical image analysis solutions.
Conference Topic
Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI
View More

Dr. Taishi Shimazaki
DVM, DJCVP, DJSTP, DJSOT – Pathologist at Japan Tobacco Inc., specializing in toxicologic pathology and AI-driven image analysis.
Conference Topic
Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI
View More

Dr. Ramesh Subbarayan
MVSc, PhD – Research Director, In-vivo Pharmacology at Syngene International, specializing in preclinical drug discovery.
Conference Topic
Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI
View More

Dr. Lars Siim Madsen
PhD – Chief Scientific Officer at Ellegaard Göttingen Minipigs with 25 years of experience in immunology, molecular biology, and biotech leadership.
Conference Topic
Göttingen Minipigs in R&D: Foundations, Applications, and Future Potential in Nonclinical Safety Assessment
View More

Dr. Venkatesha Udupa
MVSc, MSc, PhD, ERT, DABT, DSP - Senior Vice President and Head of Toxicology at Glenmark Pharmaceuticals, with over 28 years of expertise in nonclinical safety, pathology, and regulatory toxicology.
Conference Topic
Species-Specific Responses to Non-CAD Metabolite M2: Insights into Phospholipidosis and Toxicity
View More

Dr. Henglei Lu
PhD - Pathology Manager at Shanghai Institute of Materia Medica and Vice President of CPA-STP and CCVP.
Conference Topic
Introduction to Stem Cell Therapy Products and Nonclinical Safety Assessment in China
View More

Dr. Wan-Seob Cho
DVM, PhD – Professor of Veterinary Pathology at Dong-A University; expert in nanomaterial and particle toxicology.
Conference Topic
Assessment of Inhalation Toxicology and Pathology of Ultrafine Particles (UFPs) in Rats
View More

Dr. Masami Suzuki
DVM, PhD - President, The Japanese Society of Toxicologic Pathology
Head, Translational Research Division, Central Institute for Expe-rimental Medicine and Life Science
Conference Topic
Japanese Society of Toxicologic Pathology: Current Status and Future Prospects & rasH2-Tg Mouse: Development History and Production/Monitoring System
View More

SUBSCRIBE TO OUR NEWSLETTER
Our Esteemed Speakers
We are honored to welcome a distinguished panel of speakers who are pioneers in the field of toxicologic pathology, oncology research, and pharmaceutical sciences. With decades of experience spanning academia, regulatory agencies, and leading pharmaceutical companies, these experts bring a wealth of knowledge that is both deep and rare. Each speaker has significantly contributed to the advancement of science through groundbreaking research, regulatory leadership, and global collaborations.
Their insights, drawn from real-world experience and cutting-edge innovation, promise to enrich our understanding of oncology and toxicology in ways few can. This is not just a lineup of professionals — it's a gathering of minds shaping the future of medicine.
Dr. Gabriele
Pohlmeyer-Esch
DVM, Dipl. ECVP -Director of Pathology at Boehringer Ingelheim Pharma, Germany with 30+ years of experience in toxicologic pathology
Conference Topic
The Concept of Adversity in Anatomic Toxicologic Pathology
View More
Dr. Lindsay Tomlinson
DVM, DVSc – Senior veterinary pathologist with 23+ years in toxic -ologic pathology at Pfizer and Bristol-Myers Squibb.
Conference Topic
Biomarkers of Adversity
View More
Dr. Sibylle Groeters
Dipl. ECVP – Vice Presi-dent and Senior Executive Expert in Toxi-cology at BASF SE, Germany, with 20+ years of experience in toxicologic pathology.
Conference Topic
Adversity Considerations in Relation to the Agrichemical Industry
View More
Dr. Renee Hukkanen
DVM, MS, Diplomate ACVP Director of Pathology at Amgen, Inc. with experience in toxicologic pathology across pharma, chemical, and regulatory sectors.
Conference Topic
NOAEL and Adversity Assessment in Oncology Drug Development
View More
Dr. Sunish Mohanan
BVSc, MS, PhD, Diplomate ACVP – Senior Director of Research Pathobiology at Gilead Sciences with expertise in oncology, immuno-toxicology, and drug safety.
Conference Topic
Immune System Adversity: Challenges and Insights in Toxicologic Pathology
View More
Dr. Brian W. Soper
PhD - Senior Scientific Engagement Manager at The Jackson Laboratory; expert in humanized mouse platforms and immune modulation.
Conference Topic
Human HSC & PBMC Platforms for In Vivo Immune Modulatory Drug Discovery
View More
Dr. Klaus Weber
DVM, PhD, MSBiol, DJSTP –Founder, AnaPath Services GmbH, Switzerland Expert in toxicologic and human pathology with 25+ years’ experience.
Conference Topic
Innovations and Challenges in Neuropathology for Nonclinical Toxicology Studies
View More
(Day 1 - Nov 7)
(Day 2 - Nov 8)
Dr. Ken Frazier
DVM, PhD – Experimental nephrologist and retired toxicologic pathologist from GSK; expert in drug-induced kidney injury.
Conference Topic
Renal Toxicity Associated with Novel Therapeutics
View More
Dr. Shim-mo Hayashi
DVM, PhD – Fellow at Japan’s National Institute of Health Sciences and Visiting Pro-fessor at Tokyo University of Agriculture and Technology, expert in food safety and toxicologic pathology.
Conference Topic
Health Foods and Risk Assessment: Regulatory and Safety Aspects
View More
Dr. Deepa Rao
BVSc, MS, PhD, DABT, DACVP – Consulting veterinary pathologist at Greenfield Pathology Services with deep expertise in neurotoxicology and regulatory toxicologic pathology.
Conference Topic
Drug-Induced Sensory Neuropathy: Getting Aligned to Detect and Translate Neurotoxicity
View More
Dr. Padma Kumar
Narayanan
BVSc, MS, PhD – Vice President and Head of Preclinical & Clinical Development Scien-ces at Wave Life Sciences, specializing in RNA therap-eutics and immunotoxicology.
Conference Topic
The Concept of Adversity in Anatomic Toxicologic Pathology
View More
(IATP Maronpot Guest Lecture)
Dr. Bhanu Pratap
SinghBVSc, MS, DACVP, DABT, FIATP – Senior Director, Toxicologic Pathology at Gilead Sciences, with expertise in virology and long-acting injectables.
Conference Topic
Developing LongActing Injectables (LAIs): Non-Clinical Strategies and Considerations for Local Tolerability in Animal Models
View More
Dr. Alok Sharma
BVSc, MVSc, MS, PhD, DACVP, DABT - Director, Global Anatomic Pathology at Labcorp, with specialization in nervous system toxicologic pathology and direct CNS delivery studies.
Conference Topic
Direct CNS Delivery of Non-traditional Modalities: Navigating Technical Aspects and Pathology
View More
(Day 3 - Nov 9)
Dr. Kuldeep Singh
BVSc, MS, PhD, Diplomate ACVP Head of Pathology at Wave Life Sciences, specializing in toxicologic and investigative pathology with extensive experience in oligonucleotide therapeutics.
Conference Topic
Preclinical Safety Findings Asso-ciated with Systemically Admi-nistered Oligonu-cleotides (ASOs and siRNAs) and Strategies to Adjudicate Them
View More
Dr. Dinesh Bangari
BVSc, MVSc, PhD - Expert in discovery toxicology and advanced in-vitro systems with a focus on integrating AI/ML in pathology workflows.
Conference Topic
New Advanced Methodo-logies (Organoids, Organ-on-Chips, etc.) in Discovery Toxicology and AI/ML in Pathology
View More
Tijo Thomas
Head of Software Development at AIRA MATRIX, specializing in AI/ML-powered digital pathology and preclinical image analysis solutions.
Conference Topic
Streamlining Preclinical Work flows: Fast Track Approach for Development and Inte-gration of Digital Pathology and AI
View More
Dr. Taishi Shimazaki
DVM, DJCVP, DJSTP, DJSOT – Pathologist at Japan Tobacco Inc., specializing in toxicologic pathology and AI-driven image analysis.
Conference Topic
Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI
View More
Dr. Ramesh Subbarayan
MVSc, PhD – Research Director, In-vivo Pharma-cology at Syngene Inter-national, specializing in preclinical drug discovery.
Conference Topic
Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI
View More
Dr. Lars Siim Madsen
PhD - Chief Scientific Officer at Ellegaard Göttingen Minipigs with 25 years of experience in immunology, molecular biology, and biotech leadership.
Conference Topic
Göttingen Minipigs in R&D: Foundations, Applications, and Future Potential in Nonclinical Safety Assessment
View More
Dr. Udupa Venkatesh
MVSc, MSc, PhD, ERT, DABT, DSP Senior Vice President and Head of Toxicology at Glenmark Pharmaceuticals, with over 28 years of expertise in nonclinical safety, patholo-gy, and regulatory toxicology.
Conference Topic
Species-Specific Responses to Non-CAD Metabolite M2: Insights into Phospholipidosis and Toxicity
View More
Dr. Henglei Lu
Phd - Pathology Manager at Shanghai Institute of Materia Medica and Vice President of CPA-STP and CCVP.
Conference Topic
Introduction to Stem Cell Therapy Products and Nonclinical Safety Assessment in China
View More
Dr. Wan-Seob Cho
DVM, PhD - Professor of Veterinary Pathology at Dong-A University; expert in nanomaterial and particle toxicology.
Conference Topic
Assessment of Inhalation Toxicology and Pathology of Ultrafine Particles (UFPs) in Rats
View More
Dr. Masami Suzuki
DVM, PhD - President, The Japanese Society of Toxicologic Pathology
Head, Translational Research Division, Central Institute for Experimental Medicine and Life Science
Conference Topic
Japanese Society of Toxic-ologic Pathology: Current Status and Future Prospects & rasH2-Tg Mouse: Development History and Production / Monitoring System
View More

STP-I
Contact us
+91 95383 70426
+91 63521 83618
stpi.india@gmail.com
stpiconference2025@gmail.com
Society of Toxicologic Pathology, 29, 1st Cross, Malleshwaram, Bengaluru, Karnataka 560003

STP-I
Contact us
+91 95383 70426
+91 63521 83618
stpi.india@gmail.com
stpiconference2025@gmail.com
Society of Toxicologic Pathology, 29, 1st Cross, Malleshwaram, Bengaluru, Karnataka 560003